Profile data is unavailable for this security.
About the company
HighTide Therapeutics Inc is a biopharmaceutical company specializing in the discovery, development and commercialization of multifunctional, multi-targeted therapies for the treatment of metabolic and digestive diseases. The Company has developed a product pipeline of multiple product candidates in-house, covering many indications in metabolic and digestive diseases among which, some are at clinical-stage. The Company’s core product, HTD1801 (berberine ursodeoxycholate), a new molecular entity, is a gut-liver anti-inflammatory metabolic modulator which targets multiple pathways pivotal to metabolic regulation, including those associated with metabolic and digestive diseases. The Company conducts operations in the United States, Mainland China, Hong Kong and Australia.
- Revenue in HKD (TTM)0.00
- Net income in HKD-664.52m
- Incorporated2018
- Employees68.00
- LocationHighTide Therapeutics IncSouth Church Street 103,P.O. Box 10240SHENZHEN 518112ChinaCHN
- Websitehttps://www.hightidetx.com/